Science and Technology Committee (Commons)

E-cigarettes inquiry

Inquiry status: open

Accepting written evidence.

Scope of the inquiry

The Science and Technology Committee examine the impact of electronic cigarettes on human health (including their effectiveness as a stop-smoking tool), the suitability of regulations guiding their use, and the financial implications of a growing market on both business and the NHS.

Terms of reference: E-cigarettes Send a written submission

Latest evidence

  • 27 Feb 2018 - E-cigarettes - oral evidence | PDF version (PDF312 KB) HC 505 | Published 14 Mar 2018

    Evidence given by Dr Ian Jones, Vice President, Reduced-Risk Products, Japan Tobacco International, Dr Chris Proctor, Chief Scientific Officer, British American Tobacco, Dr Moira Gilchrist, Vice President, Scientific and Public Communications, Philip Morris Limited, and Dr Grant O’Connell, Regulatory and Scientific Affairs, Fontem Ventures; Professor David Harrison, Chair of the UK Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment (COC), and Dr Lynne Dawkins, Associate Professor, Centre for Addictive Behaviours Research, London South Bank University

    Watch this evidence session

Next meeting(s)

There are currently no public meetings scheduled.


Receive RSS updates

Share this page